Cite
MLA Citation
A. Pellicelli et al.. “Daclatasvir/sofosbuvir and ribavirin 800 mg flat dose is highly efficacy and safe in genotype 3 compensated and decompensated cirrhotic patients: The CLEO experience.” Digestive and liver disease, vol. 49, no. 1, n.d., pp. e64–. http://access.bl.uk/ark:/81055/vdc_100045027143.0x000046